Related Experiment Video
Updated: Jan 3, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes
Chang Yu1,2, Lehe Yang1, Mengsi Cai1
1Key Laboratory of Heart and Lung, Division of Pulmonary Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Abstract:
Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is a bifunctional enzyme located in the mitochondria. It has been reported to be overexpressed in several malignancies. However, the relationship between the expression of MTHFD2 and non-small cell lung cancer (NSCLC) remains largely unknown. In this study, we found that MTHFD2 was significantly overexpressed in NSCLC tissues and cell lines. Knockdown of MTHFD2 resulted in reduced cell growth and tumorigenicity in vitro and in vivo. Besides, the mRNA and protein expression level of cell cycle genes, such as CCNA2, MCM7 and SKP2, was decreased in MTHFD2 knockdown H1299 cells. Our results indicate that the inhibitory effect of MTHFD2 knockdown on NSCLC may be mediated via suppressing cell cycle-related genes. These findings delineate the role of MTHFD2 in the development of NSCLC and may have potential applications in the treatment of NSCLC.
Insights
Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is overexpressed in non-small cell lung cancer (NSCLC). Inhibiting MTHFD2 reduces NSCLC growth by suppressing cell cycle genes, offering potential therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Mitochondrial enzyme Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is implicated in various cancers.
- MTHFD2's role in non-small cell lung cancer (NSCLC) pathogenesis is not well-established.
- Understanding MTHFD2 expression is crucial for NSCLC research.
Purpose of the Study:
- To investigate the expression of MTHFD2 in NSCLC.
- To determine the functional role of MTHFD2 in NSCLC cell growth and tumorigenicity.
- To elucidate the molecular mechanisms underlying MTHFD2's effect on NSCLC.
Main Methods:
- Quantitative analysis of MTHFD2 expression in NSCLC tissues and cell lines.
- In vitro and in vivo experiments involving MTHFD2 knockdown (e.g., using siRNA).
- Assessment of cell proliferation, colony formation, and tumor growth.
- Analysis of cell cycle gene expression (mRNA and protein levels) post-MTHFD2 knockdown.
Main Results:
- MTHFD2 was significantly overexpressed in NSCLC tissues and cell lines.
- MTHFD2 knockdown suppressed NSCLC cell proliferation and tumorigenicity both in vitro and in vivo.
- Knockdown of MTHFD2 led to decreased expression of cell cycle genes, including CCNA2, MCM7, and SKP2.
- These findings suggest MTHFD2 promotes NSCLC development.
Conclusions:
- MTHFD2 overexpression is a feature of NSCLC.
- MTHFD2 plays a critical role in promoting NSCLC cell growth and tumorigenicity.
- The inhibitory effects of MTHFD2 knockdown are mediated through the suppression of cell cycle-related genes.
- MTHFD2 represents a potential therapeutic target for NSCLC treatment.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

